A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results
暂无分享,去创建一个
B. Jiang | Jianxiang Wang | Yanni Zhang | Wei Huang | Bo Jiang | J. Qi | Jian Li | X. Cao | Hongzhong Liu | Yi-Mo Jia | Jiyuan Guo | Yuan Meng | Mei-ying Zhang | Xiaoyu Ma | Xin-xin Cao